CM
KNSA icon

Caption Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Caption Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
+25,000
New +$1.3M 0.01% 977
2024
Q3 		– Sell
-4,065
Closed -$99K – 1459
2024
Q2 		$75.9K Sell
4,065
-1,935
-32% -$36.3K ﹤0.01% 1038
2024
Q1 		$118K Buy
+6,000
New +$117K ﹤0.01% 1042
2022
Q3 		– Sell
-1,184
Closed -$13.5K – 1686
2022
Q2 		$11K Sell
1,184
-64,439
-98% -$601K ﹤0.01% 1380
2022
Q1 		$651K Buy
65,623
+64,358
+5,088% +$682K 0.01% 1095
2021
Q4 		$14K Sell
1,265
-16,235
-93% -$200K ﹤0.01% 1530
2021
Q3 		$199K Buy
17,500
+5,500
+46% +$71.6K ﹤0.01% 1348
2021
Q2 		$168K Sell
12,000
-22,340
-65% -$339K ﹤0.01% 1192
2021
Q1 		$635K Buy
+34,340
New +$702K 0.01% 767
2020
Q4 		– Sell
-7,500
Closed -$132K – 1131
2020
Q3 		$116K Buy
+7,500
New +$141K ﹤0.01% 943

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Caption Management's KNSA Position: Q2 2026 in Review

Caption Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 25,000 shares worth $1.6M. The stake represents 0.01% of the portfolio and ranks #977 among its holdings. This is a return to the name: Caption Management previously reported a position in KNSA as recently as Q2 2024.

Caption Management first reported a position in KNSA in Q3 2020 and has held it in 10 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Caption Management held 25,000 shares of Kiniksa Pharmaceuticals worth $1.6M as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Caption Management position in Q2 2026.
  • Kiniksa Pharmaceuticals made up 0.01% of Caption Management's portfolio in Q2 2026, its #977 holding.
  • Caption Management first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and has held it in 10 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.